Suggestions

Du même auteur

Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial

Archive ouverte | Boilève, Alice | CCSD

International audience

Immune therapy for liver cancers

Archive ouverte | Hilmi, Marc | CCSD

International audience. Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) display a poor prognosis with 5-year overall survival rates around 15%, all stages taken together. These primary liver malignanc...

Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer

Archive ouverte | Neuzillet, Cindy | CCSD

International audience. Fluoropyrimidine (FP) plus platinum chemotherapy has been recently established as a second-line (L2) preferred option in advanced biliary tract cancer (aBTC) (ABC-06 phase III trial). However...

Chargement des enrichissements...